drugset / Trial / NCT03117140

Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block

NCT03117140

Phase 4 Completed 160 enrolled Melinda Seering
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a prospective randomized controlled triple-masked study looking at the duration of nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and clonidine) plus ropivacaine versus plain ropivacaine alone.

Timeline

Start
2013-12
Primary completion
2017-03
Completion
2017-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 300 ug
Subject Clonidine Other / unclassified 75 ug
Subject Dexamethasone Small molecule 8 mg
Background Ropivacaine Other / unclassified 0.75 %

Indications

No indication recorded.